Nisa Investment Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $866 | Hold |
50
| – | – | ﹤0.01% | 2763 |
|
|
2025
Q1 | $1.09K | Hold |
50
| – | – | ﹤0.01% | 2617 |
|
|
2024
Q4 | $1.6K | Sell |
50
-16,900
| -100% | -$539K | ﹤0.01% | 2560 |
|
|
2024
Q3 | $489K | Sell |
16,950
-300
| -2% | -$8.65K | ﹤0.01% | 1049 |
|
|
2024
Q2 | $662K | Sell |
17,250
-50,100
| -74% | -$1.92M | ﹤0.01% | 992 |
|
|
2024
Q1 | $3.96M | Hold |
67,350
| – | – | 0.03% | 517 |
|
|
2023
Q4 | $4.03M | Sell |
67,350
-1,000
| -1% | -$59.9K | 0.03% | 466 |
|
|
2023
Q3 | $2.6M | Buy |
68,350
+55,759
| +443% | +$2.12M | 0.02% | 592 |
|
|
2023
Q2 | $1.15M | Buy |
12,591
+2,731
| +28% | +$249K | 0.01% | 844 |
|
|
2023
Q1 | $650K | Buy |
9,860
+12
| +0.1% | +$791 | 0.01% | 980 |
|
|
2022
Q4 | $509K | Sell |
9,848
-15
| -0.2% | -$775 | ﹤0.01% | 1110 |
|
|
2022
Q3 | $657K | Buy |
9,863
+563
| +6% | +$37.5K | 0.01% | 937 |
|
|
2022
Q2 | $421K | Buy |
9,300
+7,440
| +400% | +$337K | ﹤0.01% | 1114 |
|
|
2022
Q1 | $95K | Sell |
1,860
-190
| -9% | -$9.7K | ﹤0.01% | 1627 |
|
|
2021
Q4 | $83K | Sell |
2,050
-2,902
| -59% | -$117K | ﹤0.01% | 1585 |
|
|
2021
Q3 | $163 | Buy |
4,952
+2,002
| +68% | +$66 | ﹤0.01% | 1487 |
|
|
2021
Q2 | $186 | Hold |
2,950
| – | – | ﹤0.01% | 1436 |
|
|
2021
Q1 | $127 | Hold |
2,950
| – | – | ﹤0.01% | 1649 |
|
|
2020
Q4 | $169K | Buy |
2,950
+400
| +16% | +$22.9K | ﹤0.01% | 1534 |
|
|
2020
Q3 | $77K | Buy |
2,550
+2,000
| +364% | +$60.4K | ﹤0.01% | 1629 |
|
|
2020
Q2 | $18K | Hold |
550
| – | – | ﹤0.01% | 1791 |
|
|
2020
Q1 | $15K | Buy |
+550
| New | +$15K | ﹤0.01% | 1766 |
|